Medicaid’s Best-Price Rule May Not Be Such a Big Problem
From the article:
Rachel Sachs, J.D., M.P.H., from Washington University in St. Louis, and colleagues discussed Medicaid’s “best-price rule” and the extent to which it might frustrate the goal of paying for value. According to the rule, a pharmaceutical company offering a large discount to a payer in any type of contracting agreement must make that same discount available to Medicaid. The rule is triggered when a discount exceeds the mandatory statutory rebate of 23.1 percent.
Read more here!
Read the full article
Tags
health care finance health law policy medicare-medicaid pharmaceuticals rachel sachs regulation